SUPRESS DX PEDIATRIC DROPS- dextromethorphan hydrobromide, guaifenesin, phenylephrine hydrochloride syrup 
KRAMER NOVIS

Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

----------

SUPRESS-DX PEDIATRIC DROPS

Drug Facts

Active Ingredients (in each 1 mL)

Dextromethorphan HBr, 5mg
Guaifenesin, 50mg
Phenylephrine HCl, 2.5mg

Purposes

Cough Suppressant
Expectorant
Nasal Decongestant

Uses

• helps loosen phlegm (mucus) and thin bronchial secretions to drain bronchial tubes and make coughs more productive   • temporarily relieves: • nasal congestion due to hay fever or other upper respiratory allergies (allergic rhinitis) • cough due to minor throat and bronchial irritation as may occur with the common cold

Warnings

Keep out of reach of children. In case of accidental overdose, get medical help or contact a Poison Control Center right away.

Directions

• do not use more than 6 doses in any 24-hour period • repeat every 4 hours • measure with the dosage device provided. Do not use with any other device • children 2 to under 6 years of age: 1 mL • children under 2 years of age: Consult a doctor.

Other Information

• Tamper Evident Feature: Do not use if cap seal is torn, broken or missing. • Store at controlled room temperature 15-30°C (59-86°F)

Inactive Ingredients

• Citric acid, FD&C Red 40, Flavor, Glycerin, Methylparaben, Propylene Glycol, Propylparaben, Purified Water and Sucralose.

Questions or comments?

call weekdays from 8 am to 4 pm AST at 1.787.767.2072

Sugar & Alcohol Free

Kramer Novis Pharmaceuticals within reach of patients

Manufactured in the USA for Kramer Novis, San Juan, PR 00917.   www.kramernovis.com

RETAIN CARTON FOR FULL PRESCRIBING INFORMATION

Packaging

SupresDX

SUPRESS DX PEDIATRIC DROPS 
dextromethorphan hydrobromide, guaifenesin, phenylephrine hydrochloride syrup
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:52083-055
Route of AdministrationORAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
GUAIFENESIN (UNII: 495W7451VQ) (GUAIFENESIN - UNII:495W7451VQ) GUAIFENESIN50 mg  in 1 mL
DEXTROMETHORPHAN HYDROBROMIDE (UNII: 9D2RTI9KYH) (DEXTROMETHORPHAN - UNII:7355X3ROTS) DEXTROMETHORPHAN HYDROBROMIDE5 mg  in 1 mL
PHENYLEPHRINE HYDROCHLORIDE (UNII: 04JA59TNSJ) (PHENYLEPHRINE - UNII:1WS297W6MV) PHENYLEPHRINE HYDROCHLORIDE2.5 mg  in 1 mL
Inactive Ingredients
Ingredient NameStrength
CITRIC ACID MONOHYDRATE (UNII: 2968PHW8QP)  
FD&C RED NO. 40 (UNII: WZB9127XOA)  
GLYCERIN (UNII: PDC6A3C0OX)  
METHYLPARABEN (UNII: A2I8C7HI9T)  
PROPYLENE GLYCOL (UNII: 6DC9Q167V3)  
PROPYLPARABEN (UNII: Z8IX2SC1OH)  
WATER (UNII: 059QF0KO0R)  
SUCRALOSE (UNII: 96K6UQ3ZD4)  
Product Characteristics
Colorred (CHERRY RED) Score    
ShapeSize
FlavorCHERRY (SOUR CHERRY) Imprint Code
Contains    
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:52083-055-0130 mL in 1 BOTTLE; Type 0: Not a Combination Product03/29/2011
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC monograph finalpart34103/29/2011
Labeler - KRAMER NOVIS (090158395)
Registrant - KRAMER NOVIS (090158395)

Revised: 5/2022
Document Id: e9d05532-a0d0-48e8-bd95-c6275bfbe8a5
Set id: ddb95436-7806-4086-af4d-18a6625b5c83
Version: 4
Effective Time: 20220512
 
KRAMER NOVIS